Our recombinant Protein A/G is a fusion protein that comprises of a total of 7 IgG-binding domains EDABC-C2C3. This fusion protein combines the active Fc-binding domains of Protein A and Protein G that are contained in the recombinant sequence.
The R&D pipeline for new drugs has changed considerably over the past decade.
Once dominated by big pharma and small molecules, today’s pipeline is
increasingly populated with small and emerging biotech companies developing
large molecules, or biologics, which now make up nearly 40% of the active R&D